Stuart S. Winter
University of New Mexico · 213 works · 8,846 citations · h-index 43
Top works
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
- High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
- Drug repurposing from an academic perspective
- T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434
- The genomic landscape of pediatric acute lymphoblastic leukemia
- Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
- Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
- Benign Hematogone-Rich Lymphoid Proliferations Can Be Distinguished From B-Lineage Acute Lymphoblastic Leukemia by Integration of Morphology, Immunophenotype, Adhesion Molecule Expression, and Architectural Features
- Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children’s Oncology Group AALL0434 Methotrexate Randomization
- The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia
- Risk determinants for catheter‐associated blood stream infections in children and young adults with cancer
- Absence of Biallelic TCR γ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia
- The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
- Inactivation of LEF1 in T-cell acute lymphoblastic leukemia
- Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T‐cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434
- Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
- Acute lymphoblastic leukaemia
- Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: Implications for minimal residual disease detection